These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 32696338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA, Abnous K, Badiee A, Jaafari MR.
    Colloids Surf B Biointerfaces; 2016 Mar 01; 139():228-36. PubMed ID: 26722819
    [Abstract] [Full Text] [Related]

  • 5. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M, Soudy R, El-Sikhry H, Seubert JM, Kaur K, Lavasanifar A.
    Cancer Lett; 2013 Jul 01; 334(2):284-92. PubMed ID: 23073474
    [Abstract] [Full Text] [Related]

  • 6. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M, Gheybi F, Rezayat SM, Jaafari MR.
    Eur J Pharm Sci; 2016 Apr 30; 86():125-35. PubMed ID: 26972276
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies.
    Xiao P, Zhao J, Huang Y, Jin R, Tang Z, Wang P, Song X, Zhu H, Yang Z, Yu N.
    Pharm Nanotechnol; 2020 Apr 30; 8(5):391-398. PubMed ID: 32787769
    [Abstract] [Full Text] [Related]

  • 10. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
    Paliwal SR, Paliwal R, Mishra N, Mehta A, Vyas SP.
    Curr Cancer Drug Targets; 2010 May 30; 10(3):343-53. PubMed ID: 20370682
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Membrane-Loaded Doxorubicin Liposomes Based on Ion-Pairing Technology with High Drug Loading and pH-Responsive Property.
    Xu H, Zhang L, Li L, Liu Y, Chao Y, Liu X, Jin Z, Chen Y, Tang X, He H, Kan Q, Cai C.
    AAPS PharmSciTech; 2017 Aug 30; 18(6):2120-2130. PubMed ID: 28028795
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).
    Smith B, Lyakhov I, Loomis K, Needle D, Baxa U, Yavlovich A, Capala J, Blumenthal R, Puri A.
    J Control Release; 2011 Jul 30; 153(2):187-94. PubMed ID: 21501640
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.